{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADEMT", "EGFR", "HER2", "MM-PBSA", "bitter almond", "molecular docking", "molecular dynamic"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37242487", "DateRevised": {"Year": "2023", "Month": "05", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "05", "Day": "06"}], "Language": ["eng"], "ELocationID": ["704", "10.3390/ph16050704"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "16", "Issue": "5", "PubDate": {"Year": "2023", "Month": "May", "Day": "06"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "Diosgenin and Monohydroxy Spirostanol from <i>Prunus amygdalus var amara</i> Seeds as Potential Suppressors of EGFR and HER2 Tyrosine Kinases: A Computational Approach.", "Abstract": {"AbstractText": ["Cancer continues to be leading cause of death globally, with nearly 7 million deaths per year. Despite significant progress in cancer research and treatment, there remain several challenges to overcome, including drug resistance, the presence of cancer stem cells, and high interstitial fluid pressure in tumors. To tackle these challenges, targeted therapy, specifically targeting HER2 (Human Epidermal Growth Factor Receptor 2) as well as EGFR (Epidermal Growth Factor Receptor), is considered a promising approach in cancer treatment. In recent years, phytocompounds have gained recognition as a potential source of chemopreventive and chemotherapeutic agents in tumor cancer treatment. Phytocompounds are compounds derived from medicinal plants that have the potential to treat and prevent cancer. This study aimed to investigate phytocompounds from <i>Prunus amygdalus var amara</i> seeds as inhibitors against EGFR and HER2 enzymes using in silico methods. In this study, fourteen phytocompounds were isolated from <i>Prunus amygdalus var amara</i> seeds and subjected to molecular docking studies to determine their ability to bind to EGFR and HER2 enzymes. The results showed that diosgenin and monohydroxy spirostanol exhibited binding energies comparable to those of the reference drugs, tak-285, and lapatinib. Furthermore, the drug-likeness and ADMET predictions, performed using the admetSAR 2.0 web-server tool, suggested that diosgenin and monohydroxy spirostanol have similar safety and ADMET properties as the reference drugs. To get deeper insight into the structural steadiness and flexibility of the complexes formed between these compounds and theEGFR and HER2 proteins, molecular dynamics simulations were performed for 100 ns. The results showed that the hit phytocompounds did not significantly affect the stability of the EGFR and HER2 proteins and were able to form stable interactions with the catalytic binding sites of the proteins. Additionally, the MM-PBSA analysis revealed that the binding free energy estimates for diosgenin and monohydroxy spirostanol is comparable to the reference drug, lapatinib. This study provides evidence that diosgenin and monohydroxy spirostanol may have the potential to act as dual suppressors of EGFR and HER2. Additional in vivo and in vitro research are needed to certify these results and assess their efficacy and safety as cancer therapy agents. The experimental data reported and these results are in agreement."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy Practice, College of Pharmacy, University of Hafr Al Batin, Hafr Al Batin 31991, Saudi Arabia."}], "LastName": "Shalayel", "ForeName": "Mohammed Helmy Faris", "Initials": "MHF"}, {"Identifier": ["0000-0003-4494-4284"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, University of Hafr Al Batin, Hafr Al Batin 31991, Saudi Arabia."}], "LastName": "Al-Mazaideh", "ForeName": "Ghassab M", "Initials": "GM"}, {"Identifier": ["0000-0001-6786-2156"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, University of Hafr Al Batin, Hafr Al Batin 31991, Saudi Arabia."}], "LastName": "Alanezi", "ForeName": "Abdulkareem A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, University of Hafr Al Batin, Hafr Al Batin 31991, Saudi Arabia."}], "LastName": "Almuqati", "ForeName": "Afaf F", "Initials": "AF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy Practice, College of Pharmacy, University of Hafr Al Batin, Hafr Al Batin 31991, Saudi Arabia."}], "LastName": "Alotaibi", "ForeName": "Meshal", "Initials": "M"}], "GrantList": [{"GrantID": "IFP-A-2022-2-5-21", "Agency": "University of Hafr Al-Batin", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sharma G.N., Dave R., Sanadya J., Sharma P., Sharma K. Various types and management of breast cancer: An overview. J. Adv. Pharm. Technol. Res. 2010;1:109.", "ArticleIdList": ["PMC3255438", "22247839"]}, {"Citation": "Tewari D., Patni P., Bishayee A., Sah A.N., Bishayee A. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy. Semin. Cancer Biol. 2022;80:1\u201317. doi: 10.1016/j.semcancer.2019.12.008.", "ArticleIdList": ["10.1016/j.semcancer.2019.12.008", "31866476"]}, {"Citation": "Singla R.K., Wang X., Gundamaraju R., Joon S., Tsagkaris C., Behzad S., Khan J., Gautam R., Goyal R., Rakmai J. Natural products derived from medicinal plants and microbes might act as a game-changer in breast cancer: A comprehensive review of preclinical and clinical studies. Crit. Rev. Food Sci. Nutr. 2022:1\u201345. doi: 10.1080/10408398.2022.2097196.", "ArticleIdList": ["10.1080/10408398.2022.2097196", "35838143"]}, {"Citation": "Abdolahi-Majd M., Hassanshahi G., Vatanparast M., Karimabad M.N. Investigation of the Effect of Prunus amygdalus amara on the Expression of some Genes of Apoptosis and Immortality in Breast Cancer Cells (MCF-7) Curr. Drug Res. Rev. Former. Curr. Drug Abus. Rev. 2022;14:73\u201379.", "ArticleIdList": ["34856918"]}, {"Citation": "Saati S., Dehghan P., Azizi-Soleiman F., Mobasseri M. The effect of bitter almond (Amygdalus communis L. var. Amara) gum as a functional food on metabolic profile, inflammatory markers, and mental health in type 2 diabetes women: A blinded randomized controlled trial protocol. Trials. 2023;24:35. doi: 10.1186/s13063-023-07085-7.", "ArticleIdList": ["10.1186/s13063-023-07085-7", "PMC9847170", "36650599"]}, {"Citation": "Singh D., Gohil K.J., Rajput R.T., Sharma V. Almond (Prunus amygdalus Batsch.): A Latest Review on Pharmacology and Medicinal uses. Res. J. Pharm. Technol. 2022;15:3301\u20133308. doi: 10.52711/0974-360X.2022.00553.", "ArticleIdList": ["10.52711/0974-360X.2022.00553"]}, {"Citation": "Moradi B., Heidari-Soureshjani S., Asadi-Samani M., Yang Q. A systematic review of phytochemical and phytotherapeutic characteristics of bitter almond. Int. J. Pharm. Phytopharm. Res. 2017;7:1\u20139."}, {"Citation": "Keser S., Demir E., Yilmaz O. Some Bioactive Compounds and Antioxidant Activities of the Bitter Almond Kernel (Prunus dulcis var. amara) J. Chem. Soc. Pak. 2014;36:922\u2013930."}, {"Citation": "Guici El Kouacheur K., Cherif H.S., Saidi F., Bensouici C., Fauconnier M.L. Prunus amygdalus var. amara (bitter almond) seed oil: Fatty acid composition, physicochemical parameters, enzyme inhibitory activity, antioxidant and anti-inflammatory potential. J. Food Meas. Charact. 2023;17:371\u2013384. doi: 10.1007/s11694-022-01629-2.", "ArticleIdList": ["10.1007/s11694-022-01629-2"]}, {"Citation": "Mericli F., Becer E., Kabaday\u0131 H., Hanoglu A., Yigit Hanoglu D., Ozkum Yavuz D., Ozek T., Vatansever S. Fatty acid composition and anticancer activity in colon carcinoma cell lines of Prunus dulcis seed oil. Pharm. Biol. 2017;55:1239\u20131248. doi: 10.1080/13880209.2017.1296003.", "ArticleIdList": ["10.1080/13880209.2017.1296003", "PMC6130748", "28262033"]}, {"Citation": "Uribe M.L., Marrocco I., Yarden Y. EGFR in cancer: Signaling mechanisms, drugs, and acquired resistance. Cancers. 2021;13:2748. doi: 10.3390/cancers13112748.", "ArticleIdList": ["10.3390/cancers13112748", "PMC8197917", "34206026"]}, {"Citation": "Murphrey M.B., Quaim L., Varacallo M. Biochemistry, Epidermal Growth Factor Receptor. StatPearls Publishing; Treasure Island, FL, USA: 2023.", "ArticleIdList": ["29494066"]}, {"Citation": "Rubin I., Yarden Y. The basic biology of HER2. Ann. Oncol. 2001;12:S3\u2013S8. doi: 10.1093/annonc/12.suppl_1.S3.", "ArticleIdList": ["10.1093/annonc/12.suppl_1.S3", "11521719"]}, {"Citation": "Oh D.-Y., Bang Y.-J. HER2-targeted therapies\u2014A role beyond breast cancer. Nat. Rev. Clin. Oncol. 2020;17:33\u201348. doi: 10.1038/s41571-019-0268-3.", "ArticleIdList": ["10.1038/s41571-019-0268-3", "31548601"]}, {"Citation": "Schneider M.R., Yarden Y. The EGFR-HER2 module: A stem cell approach to understanding a prime target and driver of solid tumors. Oncogene. 2016;35:2949\u20132960. doi: 10.1038/onc.2015.372.", "ArticleIdList": ["10.1038/onc.2015.372", "PMC4820040", "26434585"]}, {"Citation": "Weinberg F., Peckys D.B., de Jonge N. EGFR expression in HER2-driven breast cancer cells. Int. J. Mol. Sci. 2020;21:9008. doi: 10.3390/ijms21239008.", "ArticleIdList": ["10.3390/ijms21239008", "PMC7729501", "33260837"]}, {"Citation": "Riecke K., Witzel I. Targeting the human epidermal growth factor receptor family in breast cancer beyond HER2. Breast Care. 2020;15:579\u2013585. doi: 10.1159/000510998.", "ArticleIdList": ["10.1159/000510998", "PMC7768135", "33447231"]}, {"Citation": "Yu X., Ghamande S., Liu H., Xue L., Zhao S., Tan W., Zhao L., Tang S.-C., Wu D., Korkaya H. Targeting EGFR/HER2/HER3 with a three-in-one aptamer-siRNA chimera confers superior activity against HER2+ breast cancer. Mol. Ther. Nucleic Acids. 2018;10:317\u2013330. doi: 10.1016/j.omtn.2017.12.015.", "ArticleIdList": ["10.1016/j.omtn.2017.12.015", "PMC5862534", "29499944"]}, {"Citation": "Borrero-Garc\u00eda L.D., del Mar Maldonado M., Medina-Vel\u00e1zquez J., Troche-Torres A.L., Velazquez L., Grafals-Ruiz N., Dharmawardhane S. Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer. BMC Cancer. 2021;21:652. doi: 10.1186/s12885-021-08366-7.", "ArticleIdList": ["10.1186/s12885-021-08366-7", "PMC8170972", "34074257"]}, {"Citation": "Hsu J.L., Hung M.-C. The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer. Cancer Metastasis Rev. 2016;35:575\u2013588. doi: 10.1007/s10555-016-9649-6.", "ArticleIdList": ["10.1007/s10555-016-9649-6", "PMC5215954", "27913999"]}, {"Citation": "Schlam I., Swain S.M. HER2-positive breast cancer and tyrosine kinase inhibitors: The time is now. NPJ Breast Cancer. 2021;7:56. doi: 10.1038/s41523-021-00265-1.", "ArticleIdList": ["10.1038/s41523-021-00265-1", "PMC8137941", "34016991"]}, {"Citation": "Montemurro F., Valabrega G., Aglietta M. Lapatinib: A dual inhibitor of EGFR and HER2 tyrosine kinase activity. Expert Opin. Biol. Ther. 2007;7:257\u2013268. doi: 10.1517/14712598.7.2.257.", "ArticleIdList": ["10.1517/14712598.7.2.257", "17250463"]}, {"Citation": "Lu X., Yu H., Ma Q., Shen S., Das U.N. Linoleic acid suppresses colorectal cancer cell growth by inducing oxidant stress and mitochondrial dysfunction. Lipids Health Dis. 2010;9:106. doi: 10.1186/1476-511X-9-106.", "ArticleIdList": ["10.1186/1476-511X-9-106", "PMC2954911", "20868498"]}, {"Citation": "Amelio I., Cutruzzol\u00e1 F., Antonov A., Agostini M., Melino G. Serine and glycine metabolism in cancer. Trends Biochem. Sci. 2014;39:191\u2013198. doi: 10.1016/j.tibs.2014.02.004.", "ArticleIdList": ["10.1016/j.tibs.2014.02.004", "PMC3989988", "24657017"]}, {"Citation": "Fukuda T., Ito H., Mukainaka T., Tokuda H., Nishino H., Yoshida T. Anti-tumor promoting effect of glycosides from Prunus persica seeds. Biol. Pharm. Bull. 2003;26:271\u2013273. doi: 10.1248/bpb.26.271.", "ArticleIdList": ["10.1248/bpb.26.271", "12576693"]}, {"Citation": "Newmark J., Brady R.O., Grimley P.M., Gal A.E., Waller S.G., Thistlethwaite J.R. Amygdalin (Laetrile) and prunasin beta-glucosidases: Distribution in germ-free rat and in human tumor tissue. Proc. Natl. Acad. Sci. USA. 1981;78:6513\u20136516. doi: 10.1073/pnas.78.10.6513.", "ArticleIdList": ["10.1073/pnas.78.10.6513", "PMC349070", "6796962"]}, {"Citation": "Kashyap D., Sharma A., Tuli H.S., Sak K., Punia S., Mukherjee T.K. Kaempferol\u2013A dietary anticancer molecule with multiple mechanisms of action: Recent trends and advancements. J. Funct. Foods. 2017;30:203\u2013219. doi: 10.1016/j.jff.2017.01.022.", "ArticleIdList": ["10.1016/j.jff.2017.01.022", "PMC7104980", "32288791"]}, {"Citation": "Arya P., Kumar P. Diosgenin a steroidal compound: An emerging way to cancer management. J. Food Biochem. 2021;45:e14005. doi: 10.1111/jfbc.14005.", "ArticleIdList": ["10.1111/jfbc.14005", "34799857"]}, {"Citation": "El Sayed A.M., Basam S.M., Marzouk H.S., El-Hawary S. LC\u2013MS/MS and GC\u2013MS profiling as well as the antimicrobial effect of leaves of selected Yucca species introduced to Egypt. Sci. Rep. 2020;10:17778. doi: 10.1038/s41598-020-74440-y.", "ArticleIdList": ["10.1038/s41598-020-74440-y", "PMC7575531", "33082381"]}, {"Citation": "Shukla R., Tripathi T. Computer-Aided Drug Design. Springer; Singapore: 2020. Molecular dynamics simulation of protein and protein\u2013ligand complexes; pp. 133\u2013161."}, {"Citation": "Tautenhahn R., B\u00f6ttcher C., Neumann S. Highly sensitive feature detection for high resolution LC/MS. BMC Bioinform. 2008;9:504. doi: 10.1186/1471-2105-9-504.", "ArticleIdList": ["10.1186/1471-2105-9-504", "PMC2639432", "19040729"]}, {"Citation": "Rodriguez-Garcia M., Surman A.J., Cooper G.J., Su\u00e1rez-Marina I., Hosni Z., Lee M.P., Cronin L. Formation of oligopeptides in high yield under simple programmable conditions. Nat. Commun. 2015;6:8385. doi: 10.1038/ncomms9385.", "ArticleIdList": ["10.1038/ncomms9385", "PMC4633627", "26442968"]}, {"Citation": "Bolarinwa I.F., Orfila C., Morgan M.R. Amygdalin content of seeds, kernels and food products commercially-available in the UK. Food Chem. 2014;152:133\u2013139. doi: 10.1016/j.foodchem.2013.11.002.", "ArticleIdList": ["10.1016/j.foodchem.2013.11.002", "24444917"]}, {"Citation": "Andreotti C., Ravaglia D., Ragaini A., Costa G. Phenolic compounds in peach (Prunus persica) cultivars at harvest and during fruit maturation. Ann. Appl. Biol. 2008;153:11\u201323. doi: 10.1111/j.1744-7348.2008.00234.x.", "ArticleIdList": ["10.1111/j.1744-7348.2008.00234.x"]}, {"Citation": "Kr\u00f3l-Kogus B., G\u0142\u00f3d D., Krauze-Baranowska M. Qualitative and quantitative HPLC-ELSD-ESI-MS analysis of steroidal saponins in fenugreek seed. Acta Pharm. 2020;70:89\u201399. doi: 10.2478/acph-2020-0013.", "ArticleIdList": ["10.2478/acph-2020-0013", "31677375"]}, {"Citation": "Aertgeerts K., Skene R., Yano J., Sang B.-C., Zou H., Snell G., Jennings A., Iwamoto K., Habuka N., Hirokawa A. Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein. J. Biol. Chem. 2011;286:18756\u201318765. doi: 10.1074/jbc.M110.206193.", "ArticleIdList": ["10.1074/jbc.M110.206193", "PMC3099692", "21454582"]}, {"Citation": "Ishikawa T., Seto M., Banno H., Kawakita Y., Oorui M., Taniguchi T., Ohta Y., Tamura T., Nakayama A., Miki H. Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo [3,2-d] pyrimidine scaffold. J. Med. Chem. 2011;54:8030\u20138050. doi: 10.1021/jm2008634.", "ArticleIdList": ["10.1021/jm2008634", "22003817"]}, {"Citation": "Westbrook J., Feng Z., Chen L., Yang H., Berman H.M. The protein data bank and structural genomics. Nucleic Acids Res. 2003;31:489\u2013491. doi: 10.1093/nar/gkg068.", "ArticleIdList": ["10.1093/nar/gkg068", "PMC165515", "12520059"]}, {"Citation": "Voigtlaender M., Schneider-Merck T., Trepel M. Small Molecules in Oncology. Springer International Publishing; Cham, Switzerlands: 2018. Lapatinib; pp. 19\u201344."}, {"Citation": "Dassault Syst\u00e8mes . BIOVIA Discovery Studio 2020. Dassault Syst\u00e8mes; San Diego, CA, USA: 2019."}, {"Citation": "Land H., Humble M.S. Protein Engineering: Methods and Protocols. Humana; New York, NY, USA: 2018. YASARA: A tool to obtain structural guidance in biocatalytic investigations; pp. 43\u201367.", "ArticleIdList": ["29086303"]}, {"Citation": "Gordon J.C., Myers J.B., Folta T., Shoja V., Heath L.S., Onufriev A. H++: A server for estimating p K as and adding missing hydrogens to macromolecules. Nucleic Acids Res. 2005;33:W368\u2013W371. doi: 10.1093/nar/gki464.", "ArticleIdList": ["10.1093/nar/gki464", "PMC1160225", "15980491"]}, {"Citation": "Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30:2785\u20132791. doi: 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Forli S., Olson A.J. A force field with discrete displaceable waters and desolvation entropy for hydrated ligand docking. J. Med. Chem. 2012;55:623\u2013638. doi: 10.1021/jm2005145.", "ArticleIdList": ["10.1021/jm2005145", "PMC3319101", "22148468"]}, {"Citation": "Yang H., Lou C., Sun L., Li J., Cai Y., Wang Z., Li W., Liu G., Tang Y. admetSAR 2.0: Web-service for prediction and optimization of chemical ADMET properties. Bioinformatics. 2019;35:1067\u20131069. doi: 10.1093/bioinformatics/bty707.", "ArticleIdList": ["10.1093/bioinformatics/bty707", "30165565"]}, {"Citation": "Schmid N., Eichenberger A.P., Choutko A., Riniker S., Winger M., Mark A.E., Van Gunsteren W.F. Definition and testing of the GROMOS force-field versions 54A7 and 54B7. Eur. Biophys. J. 2011;40:843\u2013856. doi: 10.1007/s00249-011-0700-9.", "ArticleIdList": ["10.1007/s00249-011-0700-9", "21533652"]}, {"Citation": "Huang W., Lin Z., Van Gunsteren W.F. Validation of the GROMOS 54A7 force field with respect to \u03b2-peptide folding. J. Chem. Theory Comput. 2011;7:1237\u20131243. doi: 10.1021/ct100747y.", "ArticleIdList": ["10.1021/ct100747y", "26610119"]}, {"Citation": "R\u00fchle V. Pressure coupling/barostats. J. Club. 2008:1\u20135."}, {"Citation": "Berendsen H.J., Postma J.v., Van Gunsteren W.F., DiNola A., Haak J.R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 1984;81:3684\u20133690. doi: 10.1063/1.448118.", "ArticleIdList": ["10.1063/1.448118"]}, {"Citation": "Petersen H.G. Accuracy and efficiency of the particle mesh Ewald method. J. Chem. Phys. 1995;103:3668\u20133679. doi: 10.1063/1.470043.", "ArticleIdList": ["10.1063/1.470043"]}, {"Citation": "Hess B., Bekker H., Berendsen H.J., Fraaije J.G. LINCS: A linear constraint solver for molecular simulations. J. Comput. Chem. 1997;18:1463\u20131472. doi: 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H.", "ArticleIdList": ["10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H"]}, {"Citation": "Kollman P.A., Massova I., Reyes C., Kuhn B., Huo S., Chong L., Lee M., Lee T., Duan Y., Wang W. Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Acc. Chem. Res. 2000;33:889\u2013897. doi: 10.1021/ar000033j.", "ArticleIdList": ["10.1021/ar000033j", "11123888"]}, {"Citation": "Kumari R., Kumar R., Consortium O.S.D.D., Lynn A. g_mmpbsa\u2014A GROMACS tool for high-throughput MM-PBSA calculations. J. Chem. Inf. Model. 2014;54:1951\u20131962. doi: 10.1021/ci500020m.", "ArticleIdList": ["10.1021/ci500020m", "24850022"]}, {"Citation": "Verma S., Grover S., Tyagi C., Goyal S., Jamal S., Singh A., Grover A. Hydrophobic interactions are a key to MDM2 inhibition by polyphenols as revealed by molecular dynamics simulations and MM/PBSA free energy calculations. PLoS ONE. 2016;11:e0149014. doi: 10.1371/journal.pone.0149014.", "ArticleIdList": ["10.1371/journal.pone.0149014", "PMC4749206", "26863418"]}, {"Citation": "Homeyer N., Gohlke H. Free energy calculations by the molecular mechanics Poisson\u2212Boltzmann surface area method. Mol. Inform. 2012;31:114\u2013122. doi: 10.1002/minf.201100135.", "ArticleIdList": ["10.1002/minf.201100135", "27476956"]}, {"Citation": "Shalayel M.H.F., Al-Mazaideh G.M., Alanezi A.A., Almuqati A.F., Alotaibi M. The Potential Anti-Cancerous Activity of Prunus amygdalus var. amara Extract. Processes. 2023;11:1277. doi: 10.3390/pr11041277.", "ArticleIdList": ["10.3390/pr11041277", "PMC10223344", "37242487"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "3", "Day": "8"}, {"Year": "2023", "Month": "4", "Day": "20"}, {"Year": "2023", "Month": "4", "Day": "24"}, {"Year": "2023", "Month": "5", "Day": "27", "Hour": "9", "Minute": "44"}, {"Year": "2023", "Month": "5", "Day": "27", "Hour": "9", "Minute": "43"}, {"Year": "2023", "Month": "5", "Day": "27", "Hour": "1", "Minute": "28"}, {"Year": "2023", "Month": "5", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["37242487", "PMC10223344", "10.3390/ph16050704", "ph16050704"]}}], "PubmedBookArticle": []}